Little Green Pharma Ltd reported earnings results for the half year ended September 30, 2022. For the half year, the company reported sales was AUD 9.16 million compared to AUD 7.32 million a year ago. Net loss was AUD 7.83 million compared to AUD 8.58 million a year ago.

Basic loss per share from continuing operations was AUD 0.0312 compared to AUD 0.0365 a year ago. Diluted loss per share from continuing operations was AUD 0.0312 compared to AUD 0.0365 a year ago. Basic loss per share was AUD 0.0326 compared to AUD 0.0365 a year ago.

Diluted loss per share was AUD 0.0326 compared to AUD 0.0365 a year ago.